89bio Inc (ETNB)

8.75 -0.16 (-1.85%) USD  |  NASDAQ  |  Nov 14, 16:00
8.50 -0.25 (-2.86%) After-Hours: 20:00
More

89bio Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for ETNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Non-Current Deferred Revenue (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

Madrigal Pharmaceuticals Inc --
Eli Lilly and Co --
Viking Therapeutics Inc --
Akero Therapeutics Inc --
NovaBay Pharmaceuticals Inc --